חזרה לתוצאות החיפוש

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Chemotherapy Induced Peripheral Neuropathy (CIPN)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Palomar Health (Topography), Poway, California, United States

  • Eastern Connecticut Hematology Oncology, Norwich, Connecticut, United States

    Contact: Principal Investigator (Dr. Dennis Slater)

  • Hialeah Hospital, Hialeah, Florida, United States

    Contact: Study coordinator (Adrian Almarales) · aalmarales@bioresearchpartner.com · 833-489-4968
    Contact: Principal Investigator (Dr. Luis Rangel)

  • Hawaii Cancer Care, Honolulu, Hawaii, United States

    Contact: Study coordinator (Isobel Webster) · isobel.webster@AONcology.com · 808-524-6115
    Contact: Principal Investigator (Dr. Ashley Springer)

  • Hope and Healing Cancer Services, Hinsdale, Illinois, United States

    Contact: Study coordinator (Ava Baftirovska) · abaftirovska@hopenheal.care · (630) 560-0121
    Contact: Principal Investigator (Dr. Srilata Gundala)

  • Parkview Cancer Institute, Fort Wayne, Indiana, United States

    Contact: Principal Investigator (Dr. Joseph McCollom)

  • Health Partners Frauenshuh Cancer Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Jacquelyn Christenson) · jacquelyn.christenson@parknicollet.com · 612-341-4800
    Contact: Principal Investigator (Dr. Rachel Lerner)

  • Fairview Masonic Cancer Clinic, University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Principal Investigator (Dr. Melissa Geller)

  • Astera Cancer Care, East Brunswick, New Jersey, United States

    Contact: Study coordinator (Percy Yeung) · Percy.yeung@asterahealthcare.org · 732 387 3378
    Contact: Principal Investigator (Dr. Siu-Long Yao)

  • Inspira Medical Center Mullica Hill, Mullica Hill, New Jersey, United States

    Contact: Principal Investigator (Dr. Erev Tubb)

  • Inspira Health - Vineland, Vineland, New Jersey, United States

    Contact: Principal Investigator (Dr. Mylene Go)

  • New York Cancer and Blood Specialists, New York, New York, United States

    Contact: Principal Investigator (Dr. Richard Zuniga)

  • Springfield Regional Cancer Center, Springfield, Ohio, United States

    Contact: Study coordinator (Tracy Adrian) · tadrian@sorcc.org · 937-323-5554
    Contact: Principal Investigator (Dr. Zaw Min Bo)

  • Mercy Health St. Elizabeth Hospital, Youngstown, Ohio, United States

    Contact: Study coordinator (Jo Wilms) · JWilms@mercy.com · 330-240-4616
    Contact: Principal Investigator (Dr. James Kim)

  • Providence Cancer Institute, Portland, Oregon, United States

    Contact: Principal Investigator (Dr. David Page)

  • Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Principal Investigator (Dr. Rajiv Agarwal)

  • Hospital Sisters Health System - St.Vincent & St.Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Jessica Franzke) · Jessica.Franzke@hshs.org · 920-433-8795
    Study coordinator · brian.burnette@hshs.org
    Contact: Principal Investigator (Dr. Brian Burnette)

  • St. James Hospital, Dublin, Dublin, Ireland

    Contact: Principal Investigator (Professor Maeve Lowery)
צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)